Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Who is developing Orforglipron
The GLP-1 receptor agonists are successful in the treatment of type-2 diabetes and the treatment of obesity, with a variety of additional benefits currently being explored
Nasal spray device selection Not all spray devices are equal for peptide delivery
Eating smaller, more frequent meals and avoiding high-fat foods can reduce nausea
Here is how the three compare
In the STEP 1 clinical trial published in the New England Journal of Medicine, adults on weekly semaglutide 2.4 mg lost an average of about 15% of body weight over 68 weeks alongside lifestyle changes
US$ 27.96
US$ 20.96
US$ 28.52
US$ 21.70
